The Charles T. Campbell Eye Microbiology Lab
UPMCUniversity of Pittsburgh Schools of the Health Sciences
HomeContact InformationLab Diagnostic TestingAntibiotic SusceptibilityAntimicrobial TherapyCurrent ResearchPhotos

Ocular Microbiology and Immunology Group
Back to OMIG Main Page

< Previous | 2020 Agenda and Abstracts | Next >


2020 OMIG Abstract

Matrix Metalloproteinase 9 Positivity Predicts Long Term Decreased Tear Production

Matias Soifer1,2, Hazem M Mousa1,2, Sandra S. Stinnett2, Anat Galor, MD3,4, and Victor L. Perez, MD1,2
1Foster Center for Ocular Immunology, Duke Eye Institute, Durham, NC; 2Department of Ophthalmology, Duke University Medical Center, Durham, NC; 3Miami Veterans Administration Medical Center, Miami, FL;
4Bascom Palmer Eye Institute, University of Miami, Miami, FL

Purpose: To investigate long-term correlations between Matrix Metalloproteinase-9 (MMP-9) testing and dry eye (DE) parameters. Additionally, to evaluate variability in MMP-9 results over time and with anti-inflammatory treatment.

Methods:: Retrospective cohort study of DE patients with equal MMP-9 testing results (positive or negative) in both eyes and a minimum of 6 months of follow up. Our main outcome measure was to examine whether initial MMP-9 status affected change in DE parameters over time. Secondarily, we evaluated the frequency of MMP-9 status change over time and examined whether it was impacted by treatment.

Results: 67 patients (76% female) fit the inclusion criteria. Mean age was 63 years with a mean follow up of 10.6 months. The majority (55%) had concomitant systemic immune disease. MMP-9 testing was positive in both eyes in 39 individuals (58%) and negative in both eyes in 27 (42%) Individuals in the MMP-9 positive group had a greater decrease in production from baseline to final visit compared to the negative group (-2.6 vs 2.1, P=0.013). In those initially MMP-9 positive, the frequency of becoming MMP-9 negative was higher in eyes treated with anti-inflammatory therapy compared to artificial tears (22.9% vs 3.3%, P=0.106). However, only Lifitegrast 5% showed statistical significance compared to artificial tears (31.3% vs 3.3%, P=0.044).

Conclusion: Eyes with detectable MMP-9 had significantly decreased tear production over time compared to those without detectable MMP-9. Anti-inflammatory treatment more frequently normalized MMP-9 compared to PFATs.

Disclosure: N (M Soifer, HM Mousa, S Stinnett); C: (A Galor, Novaliq, Dompe, Novartis) (VL Perez, Alcon, Eyegate, Novaliq, Trefoil, Quidel); O: (VL Perez, OBTears)



< Previous | 2020 Agenda and Abstracts | Next >